Prediction of Positions of Active Compounds Makes It Possible To Increase Activity in Fragment-Based Drug Development.

about

Prediction of Positions of Active Compounds Makes It Possible To Increase Activity in Fragment-Based Drug Development.

Item

http://www.wikidata.org/entity/Q46065964

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Prediction of Positions of Act ...... agment-Based Drug Development.

@en

Prediction of Positions of Act ...... agment-Based Drug Development.

@nl

type

Item

label

Prediction of Positions of Act ...... agment-Based Drug Development.

@en

Prediction of Positions of Act ...... agment-Based Drug Development.

@nl

prefLabel

Prediction of Positions of Act ...... agment-Based Drug Development.

@en

Prediction of Positions of Act ...... agment-Based Drug Development.

@nl

P1476

Prediction of Positions of Act ...... ragment-Based Drug Development

@en

P2093

Yoshifumi Fukunishi

http://www.w3.org/2001/XMLSchema#string

P2860

3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 1. Lead finding

Identification of novel binding interactions in the development of potent, selective 2-naphthamidine inhibitors of urokinase. Synthesis, structural analysis, and SAR of N-phenyl amide 6-substitution

Flipped out: structure-guided design of selective pyrazolylpyrrole ERK inhibitors

Syntheses of potent, selective, and orally bioavailable indazole-pyridine series of protein kinase B/Akt inhibitors with reduced hypotension

Discovery and design of novel HSP90 inhibitors using multiple fragment-based design strategies

Recent developments in fragment-based drug discovery

Synthesis and biological evaluation of coumarin-based inhibitors of NAD(P)H: quinone oxidoreductase-1 (NQO1)

Janus kinase 2 inhibitors. Synthesis and characterization of a novel polycyclic azaindole

Entropic contribution to the linking coefficient in fragment based drug design: a case study

Development and testing of a general amber force field

P304

758-769

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/PH4050758

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P932

4055877

http://www.w3.org/2001/XMLSchema#string